These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1745887)

  • 1. [Type 1 or Type 2 diabetes: diagnostic aids in clinically uncertain cases].
    Spinas GA
    Schweiz Rundsch Med Prax; 1991 Dec; 80(49):1367-8. PubMed ID: 1745887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical heterogeneity of childhood diabetes in Baranya county].
    Makovi H; Soltész G; Hermann R
    Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E; Ocenásová A; Straková J; Mokán M
    Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term course of type I-simulating type II-diabetes mellitus].
    Lohmann D; Verlohren HJ; Borsdorf G; Brunner E; Bierwolf B; Richter HV
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):241-4. PubMed ID: 6391902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J; Bárová H; Hill M; Masek Z
    Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetes mellitus.
    Larger E; Dubois-Laforgue D
    Ann Med Interne (Paris); 1999 Apr; 150(3):254-63. PubMed ID: 10445097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differential diagnosis of diabetes mellitus in adults: assessment of immunogenetic markers of insulin dependence].
    Turiev GS; Ametov AS; Kondrat'ev IaIu; Timofeev AV
    Klin Med (Mosk); 2004; 82(1):47-52. PubMed ID: 15022597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C-peptide in blood].
    Matsuda A
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():35-9. PubMed ID: 9513385
    [No Abstract]   [Full Text] [Related]  

  • 9. [New diagnostic tests for diabetes mellitus. C-peptide and proinsulin].
    Matsuda A
    Nihon Rinsho; 1989 Nov; 47(11):2495-500. PubMed ID: 2601062
    [No Abstract]   [Full Text] [Related]  

  • 10. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
    Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
    Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of basal C peptide and its relationship with pancreatic autoantibodies in young adults with type 2 diabetes mellitus.
    Vlad A; Serban V; Sima A; Timar R; Roşu M
    Rom J Intern Med; 2004; 42(2):333-41. PubMed ID: 15529624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies.
    Batstra MR; Aanstoot HJ; Herbrink P
    Clin Lab; 2001; 47(9-10):497-507. PubMed ID: 11596913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem?
    Rosenbloom AL
    Pediatr Diabetes; 2007 Apr; 8(2):51-2. PubMed ID: 17448126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes].
    Młynarski W; Wyka K; Bodalska-ŁIpińska J; Andrzejewski W; Zmysłowska A; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):17-22. PubMed ID: 12831633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a relationship between islet cell surface antibodies and clinical, biochemical, hormonal, and immunogenetic parameters in newly diagnosed type I diabetics?
    Michaelis D; Rjasanowski I; Ratzmann KP; Strese J; Dietz H; Hildmann W
    Acta Biol Med Ger; 1982; 41(12):1093-8. PubMed ID: 6765149
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic value of serum islet autoantibody in hepatogenic diabetes mellitus].
    Zhang L; Shi YL; Hong WX; Jia WD; Li LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1034-6. PubMed ID: 16864107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide used in the estimation of islet beta-cell function in diabetes.
    Gjessing HJ
    Dan Med Bull; 1992 Oct; 39(5):438-52. PubMed ID: 1424818
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
    Monge L; Bruno G; Pinach S; Grassi G; Maghenzani G; Dani F; Pagano G
    Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.